These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 2199446
21. Purification and structural characterization of the putative gag-pol protease of human immunodeficiency virus. Lillehoj EP, Salazar FH, Mervis RJ, Raum MG, Chan HW, Ahmad N, Venkatesan S. J Virol; 1988 Aug; 62(8):3053-8. PubMed ID: 3292793 [Abstract] [Full Text] [Related]
22. Identification of a human immunodeficiency virus-1 protease cleavage site within the 66,000 Dalton subunit of reverse transcriptase. Graves MC, Meidel MC, Pan YC, Manneberg M, Lahm HW, Grüninger-Leitch F. Biochem Biophys Res Commun; 1990 Apr 16; 168(1):30-6. PubMed ID: 1691640 [Abstract] [Full Text] [Related]
23. Inhibition of HIV by an anti-HIV protease synthetic peptide blocks an early step of viral replication. Venaud S, Yahi N, Fehrentz JL, Guettari N, Nisato D, Hirsch I, Chermann JC. Res Virol; 1992 Apr 16; 143(5):311-9. PubMed ID: 1480823 [Abstract] [Full Text] [Related]
24. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1. Barrie KA, Perez EE, Lamers SL, Farmerie WG, Dunn BM, Sleasman JW, Goodenow MM. Virology; 1996 May 15; 219(2):407-16. PubMed ID: 8638406 [Abstract] [Full Text] [Related]
25. Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production. Park J, Morrow CD. J Virol; 1991 Sep 15; 65(9):5111-7. PubMed ID: 1870215 [Abstract] [Full Text] [Related]
26. Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor. Debouck C, Gorniak JG, Strickler JE, Meek TD, Metcalf BW, Rosenberg M. Proc Natl Acad Sci U S A; 1987 Dec 15; 84(24):8903-6. PubMed ID: 3321060 [Abstract] [Full Text] [Related]
27. Affinity purification of HIV-1 and HIV-2 proteases from recombinant E. coli strains using pepstatin-agarose. Rittenhouse J, Turon MC, Helfrich RJ, Albrecht KS, Weigl D, Simmer RL, Mordini F, Erickson J, Kohlbrenner WE. Biochem Biophys Res Commun; 1990 Aug 31; 171(1):60-6. PubMed ID: 2203350 [Abstract] [Full Text] [Related]
28. Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid. Pettit SC, Simsic J, Loeb DD, Everitt L, Hutchison CA, Swanstrom R. J Biol Chem; 1991 Aug 05; 266(22):14539-47. PubMed ID: 1860860 [Abstract] [Full Text] [Related]
29. N myristylation of the human immunodeficiency virus type 1 gag polyprotein precursor in Saccharomyces cerevisiae. Bathurst IC, Chester N, Gibson HL, Dennis AF, Steimer KS, Barr PJ. J Virol; 1989 Jul 05; 63(7):3176-9. PubMed ID: 2657103 [Abstract] [Full Text] [Related]
30. Mutating P2 and P1 residues at cleavage junctions in the HIV-1 pol polyprotein. Effects on hydrolysis by HIV-1 proteinase. Jupp RA, Phylip LH, Mills JS, Le Grice SF, Kay J. FEBS Lett; 1991 Jun 03; 283(2):180-4. PubMed ID: 2044756 [Abstract] [Full Text] [Related]
31. Hydrolysis of synthetic chromogenic substrates by HIV-1 and HIV-2 proteinases. Phylip LH, Richards AD, Kay J, Kovalinka J, Strop P, Blaha I, Velek J, Kostka V, Ritchie AJ, Broadhurst AV. Biochem Biophys Res Commun; 1990 Aug 31; 171(1):439-44. PubMed ID: 2203349 [Abstract] [Full Text] [Related]
32. Autoprocessing of the human immunodeficiency virus type 1 protease precursor expressed in Escherichia coli from a synthetic gene. Valverde V, Lemay P, Masson JM, Gay B, Boulanger P. J Gen Virol; 1992 Mar 31; 73 ( Pt 3)():639-51. PubMed ID: 1545221 [Abstract] [Full Text] [Related]
33. Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease. Grant SK, Deckman IC, Minnich MD, Culp J, Franklin S, Dreyer GB, Tomaszek TA, Debouck C, Meek TD. Biochemistry; 1991 Aug 27; 30(34):8424-34. PubMed ID: 1883829 [Abstract] [Full Text] [Related]
34. Identification of proteolytic processing sites within the Gag and Pol polyproteins of feline immunodeficiency virus. Elder JH, Schnölzer M, Hasselkus-Light CS, Henson M, Lerner DA, Phillips TR, Wagaman PC, Kent SB. J Virol; 1993 Apr 27; 67(4):1869-76. PubMed ID: 8383214 [Abstract] [Full Text] [Related]
35. Expression and purification of the mouse mammary tumor virus gag-pro transframe protein p30 and characterization of its dUTPase activity. Köppe B, Menéndez-Arias L, Oroszlan S. J Virol; 1994 Apr 27; 68(4):2313-9. PubMed ID: 8139016 [Abstract] [Full Text] [Related]
36. Amino acids encoded downstream of gag are not required by Rous sarcoma virus protease during gag-mediated assembly. Bennett RP, Rhee S, Craven RC, Hunter E, Wills JW. J Virol; 1991 Jan 27; 65(1):272-80. PubMed ID: 1845888 [Abstract] [Full Text] [Related]
37. Rational design of peptide-based HIV proteinase inhibitors. Roberts NA, Martin JA, Kinchington D, Broadhurst AV, Craig JC, Duncan IB, Galpin SA, Handa BK, Kay J, Kröhn A. Science; 1990 Apr 20; 248(4953):358-61. PubMed ID: 2183354 [Abstract] [Full Text] [Related]
38. Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain. Zybarth G, Kräusslich HG, Partin K, Carter C. J Virol; 1994 Jan 20; 68(1):240-50. PubMed ID: 8254734 [Abstract] [Full Text] [Related]